Ruiling Xiao

Peking Union Medical College Hospital, Peking Union Medical College
Beijing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Spatial transcriptomics defines the molecular progression, invasion and immune landscape of IPMN and IPMN-derived pancreatic cancer.

Spatial transcriptomics defines the molecular progression, invasion and immune landscape of IPMN and IPMN-derived pancreatic cancer.

Journal: Gut

Published: June 10, 2025

FOLR2+ macrophages in cancer: allies or enemies.

FOLR2+ macrophages in cancer: allies or enemies.

Journal: Cell communication and signaling : CCS

Published: April 07, 2025

Comparative spatial transcriptomics of pancreatic cancer with ductal and acinar origins in mouse models.

Comparative spatial transcriptomics of pancreatic cancer with ductal and acinar origins in mouse models.

Journal: Clinical and translational medicine

Published: March 23, 2025

Sialic Acids: Sweet modulators fueling cancer cells and domesticating the tumor microenvironment.

Sialic Acids: Sweet modulators fueling cancer cells and domesticating the tumor microenvironment.

Journal: Cancer letters

Published: March 10, 2025

Targeting metabolic-epigenetic-immune axis in cancer: molecular mechanisms and therapeutic implications.

Targeting metabolic-epigenetic-immune axis in cancer: molecular mechanisms and therapeutic implications.

Journal: Signal transduction and targeted therapy

Published: February 16, 2025

Cancer cell-derived sialylated IgG interacting with Siglec-7/9/10 is a potential immunotherapeutic target in pancreatic cancer.

Cancer cell-derived sialylated IgG interacting with Siglec-7/9/10 is a potential immunotherapeutic target in pancreatic cancer.

Journal: Cell reports. Medicine

Published: December 15, 2024

Machine learning based identification of an amino acid metabolism related signature for predicting prognosis and immune microenvironment in pancreatic cancer.

Machine learning based identification of an amino acid metabolism related signature for predicting prognosis and immune microenvironment in pancreatic cancer.

Journal: BMC cancer

Published: June 10, 2024

Enhancer reprogramming: critical roles in cancer and promising therapeutic strategies.

Enhancer reprogramming: critical roles in cancer and promising therapeutic strategies.

Journal: Cell death discovery

Published: April 16, 2024

Histone lactylation dynamics: Unlocking the triad of metabolism, epigenetics, and immune regulation in metastatic cascade of pancreatic cancer.

Histone lactylation dynamics: Unlocking the triad of metabolism, epigenetics, and immune regulation in metastatic cascade of pancreatic cancer.

Journal: Cancer letters

Published: April 06, 2024

Comprehensive analysis of bulk and single-cell transcriptomic data reveals a novel signature associated with endoplasmic reticulum stress, lipid metabolism, and liver metastasis in pancreatic cancer.

Comprehensive analysis of bulk and single-cell transcriptomic data reveals a novel signature associated with endoplasmic reticulum stress, lipid metabolism, and liver metastasis in pancreatic cancer.

Journal: Journal of translational medicine

Published: December 12, 2023

Crosstalk between metabolic remodeling and epigenetic reprogramming: A new perspective on pancreatic cancer.

Crosstalk between metabolic remodeling and epigenetic reprogramming: A new perspective on pancreatic cancer.

Journal: Cancer letters

Published: July 18, 2023

Comprehensive multi-omics profiling identifies novel molecular subtypes of pancreatic ductal adenocarcinoma.

Comprehensive multi-omics profiling identifies novel molecular subtypes of pancreatic ductal adenocarcinoma.

Journal: Genes & diseases

Published: May 19, 2023

Showing 1-12 of 12

Last Updated: 09/26/2026